I'm not sure that their issue was competitors. I think it was more to do with media coverage & a resulting class action which seems to be becoming less & less significant as time passes.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025